Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization.
Dowling, J.E., Chuaqui, C., Pontz, T.W., Lyne, P.D., Larsen, N.A., Block, M.H., Chen, H., Su, N., Wu, A., Russell, D., Pollard, H., Lee, J.W., Peng, B., Thakur, K., Ye, Q., Zhang, T., Brassil, P., Racicot, V., Bao, L., Denz, C.R., Cooke, E.(2012) ACS Med Chem Lett 3: 278-283
- PubMed: 24900464 
- DOI: https://doi.org/10.1021/ml200257n
- Primary Citation of Related Structures:  
3U4U - PubMed Abstract: 
In this paper we describe a series of 3-cyano-5-aryl-7-aminopyrazolo[1,5-a]pyrimidine hits identified by kinase-focused subset screening as starting points for the structure-based design of conformationally constrained 6-acetamido-indole inhibitors of CK2. The synthesis, SAR, and effects of this novel series on Akt signaling and cell proliferation in vitro are described.
Organizational Affiliation: 
AstraZeneca , Oncology Innovative Medicines Unit, 35 Gatehouse Drive, Waltham, Massachusetts 02145, United States.